Sensi Agentic Operating System for Senior Care

Sensi AI is a senior care technology company headquartered at 701 Brazos Street, Austin, Texas, according to its website. It serves home care agencies, senior living communities and families, with a focus on assessments, early risk detection and agency operations.

The platform is presented as an agentic operating system with three agent modules: Sensi Agent for Care (always-on assessments, predictive insights, real-time alerts), Agent for Growth (inside sales, CRM, lead nurture) and Agent for Ops (centralised messaging, caregiver oversight, callout coverage). Customers shown include Visiting Angels, Senior Helpers and Synergy Home Care franchise offices.

• Always-on assessments: Continuous care assessments with predictive insights and real-time alerts.
• Care visualisation: Dashboards of client status for care teams, families and communities.
• Sensi Solo Care: A mode aimed at seniors living on their own.
• Growth agent: Inside sales, self-updating CRM and automated lead nurture.
• Ops agent: Centralised messaging, caregiver oversight and automated callout coverage.
• Concierge: A 24/7 virtual concierge for clients and families.

Home care service companies in Vietnam can use it to coordinate caregivers and track client status. Elderly care centres can use alerts for early detection of health decline. Franchise networks can centralise lead handling and scheduling.

Always-on assessments and real-time alerts help agencies detect health changes earlier. Sales and operations agents reduce administrative work for agency staff. The vendor reports 22 percent fewer hospitalisations and 2X length of stay, which are company claims without a stated method.

Home care agencies face caregiver shortages and rising demand from ageing clients, which is driving adoption of AI for assessment and operations. Vietnam's home care and elderly service providers are early-stage and could adopt similar care-management and monitoring tools.

Headquartered in Austin, Texas. The press list on the website reports a USD 45 million Series C in October 2025 and a USD 31 million Series B in June 2024. The TIME World's Top HealthTech Companies 2026 list is also cited.